Health in Tuvalu 862 indicators covering health for Tuvalu. IndicatorLatest Year10-yr change Rank Mortality rate age 10-19 - Remains constant 6.08 2030 down 0.9% 78th Mortality rate age 10-19 - Current trends maintained 5.43 2030 down 9.8% 81st Mortality rate age 10-19 - High-income country average rate matched 3.74 2030 down 30.0% 80th Neonatal deaths - Remains constant 1 2030 down 50.0% 191st Neonatal deaths - Current trends maintained 1 2030 down 50.0% 191st Neonatal deaths - SDG target met 1 2030 down 50.0% 191st Under-five deaths - Remains constant 3 2030 down 25.0% 191st Under-five deaths - Current trends maintained 3 2030 down 25.0% 190th Under-five deaths - SDG target met 3 2030 down 25.0% 190th Deaths age 10 to 19 - Remains constant 1 2030 unchanged 189th Deaths age 10 to 19 - Current trends maintained 1 2030 unchanged 189th Countries with birth registration data that are at least 90 percent 0 2024 — 144th Ipv vaccine coverage 99 2024 unchanged 1st Tb patients living with hiv receiving art 0 2021 — 141st New leprosy case detection rate per 1 000 000 population 972.42 2022 up 219.6% 2nd Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 97.0% 2025 — 29th Leprosy registered prevalence rate per 1 000 000 population 357.01 2021 up 17.3% 4th Leprosy - Number of new leprosy cases among children 1 2021 — 59th Leprosy - Number of cases registered for treatment 4 2021 up 33.3% 99th New leprosy child case detection rate (less than 15 years of age) per 282.09 2021 — 4th Ipv1 number unvaccinated 2.19 2023 down 11.7% 191st Age-standardized prevalence of current tobacco use among persons aged 33.4% 2024 down 12.3% 17th Number of female leprosy new cases 2 2021 — 83rd National smoking ban: NUMBER OF PLACES SMOKE-FREE 4 2022 unchanged 114th Number of prevalent tuberculosis cases 24 2014 down 51.0% 177th Number of new G2D leprosy cases 2 2021 — 71st Leprosy - New leprosy cases with G2D rate per 1 000 000 population 178.51 2021 — 1st 3.7.2 Adolescent birth rate per 1,000 women 40 2017 up 40.3% 83rd 3.1.2 Proportion of births attended by skilled health personnel 100 2020 up 7.4% 1st Inflation-adjusted prices for most sold brand of cigarettes: Prices 9.03 2022 up 36.8% 45th Taxes as a % of price: total tax 35.5% 2022 up 139.5% 144th Taxes as a % of price: value added tax 2.9% 2022 down 24.9% 169th Taxes as a % of price: ad valorem excise 17.2% 2022 up 78.2% 65th Taxes as a % of price: specific excise 0.0% 2022 — 135th Taxes as a % of price: import duties 15.4% 2022 up 1,074.0% 12th Taxes as a % of price: other taxes 0.0% 2022 — 57th Inflation-adjusted prices for most sold brand of cigarettes: Price in 13 2022 up 48.2% 122nd Physical activity policies for activie societies 20 2023 up 100.0% 2nd Physical activity policies focused on active systems 10 2023 unchanged 101st 3.8.1 Coverage of essential health services 52 2021 up 6.1% 142nd Affordability - percentage of GDP per capita required to purchase 15.45 2022 down 10.3% 16th Deaths and missing persons due to natural disasters 0 2022 — 117th Hiv expenditure 34,455 2013 down 65.6% 97th Number of new leprosy cases with G2D among children 1 2021 — 25th Most sold brand of cigarettes - price in currency reported 6 2020 unchanged 148th Most sold brand of cigarettes - taxes as a % of price - total tax 0.4% 2020 up 143.8% 136th Most sold brand of cigarettes - taxes as a % of price - ad valorem 0.0% 2020 down 72.7% 103rd Most sold brand of cigarettes - taxes as a % of price - other taxes 0.0% 2020 — 42nd Most sold brand of cigarettes - taxes as a % of price - import duties 0.3% 2020 up 1,550.0% 5th Most sold brand of cigarettes - taxes as a % of price - value added 0.0% 2020 unchanged 161st Most sold brand of cigarettes - taxes as a % of price - specific 0.0% 2020 — 129th Most sold brand of cigarettes - price in US$ at official exchange 4.31 2020 down 20.0% 66th Most sold brand of cigarettes - price in PPP$ 4.31 2020 down 14.7% 117th Number of non-autochthonous leprosy cases 0 2021 — 47th Population with basic handwashing facilities at home 96.3% 2024 unchanged 11th HPV immunization coverage estimates among primary target cohort (9-14) 78.0% 2025 — 43rd Tuberculosis - new and relapse cases 12 2011 down 25.0% 176th Percentage of principal display area mandated to be covered by health 30 2022 unchanged 127th New cases: pulmonary smear-negative 2 2012 — 176th Percentage of principal display area mandated to be covered by health 30 2022 unchanged 118th ← Previous Page 14 of 15 Next →